177 related articles for article (PubMed ID: 27536367)
1. Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinoma.
Schmidt A; Bloechinger M; Weber A; Siveke J; von Delius S; Prinz C; Schmitt W; Schmid RM; Neu B
United European Gastroenterol J; 2016 Aug; 4(4):570-9. PubMed ID: 27536367
[TBL] [Abstract][Full Text] [Related]
2. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.
Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY
Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of survival of advanced hilar cholangiocarcinoma after biliary drainage alone versus photodynamic therapy with external drainage].
Cheon YK; Cho YD; Baek SH; Cha SW; Moon JH; Kim YS; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2004 Nov; 44(5):280-7. PubMed ID: 15564808
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic Therapy (PDT), Radiofrequency Ablation (RFA) With Biliary Stents in Palliative Treatment of Unresectable Extrahepatic Cholangiocarcinoma: A Systematic Review and Meta-analysis.
Mohan BP; Chandan S; Khan SR; Kassab LL; Ponnada S; Artifon ELA; Otoch JP; McDonough S; Adler DG
J Clin Gastroenterol; 2022 Feb; 56(2):e153-e160. PubMed ID: 33780214
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with polyhematoporphyrin for malignant biliary obstruction: A nationwide retrospective study of 150 consecutive applications.
Dolak W; Schwaighofer H; Hellmich B; Stadler B; Spaun G; Plieschnegger W; Hebenstreit A; Weber-Eibel J; Siebert F; Emmanuel K; Knoflach P; Gschwantler M; Vogel W; Trauner M; Püspök A;
United European Gastroenterol J; 2017 Feb; 5(1):104-110. PubMed ID: 28405328
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intraluminal radiofrequency ablation and stents vs. stents alone in the management of malignant biliary obstruction.
Cui W; Wang Y; Fan W; Lu M; Zhang Y; Yao W; Li J
Int J Hyperthermia; 2017 Nov; 33(7):853-861. PubMed ID: 28540797
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic radiofrequency ablation for malignant biliary strictures.
Wang F; Li Q; Zhang X; Jiang G; Ge X; Yu H; Nie J; Ji G; Miao L
Exp Ther Med; 2016 Jun; 11(6):2484-2488. PubMed ID: 27284336
[TBL] [Abstract][Full Text] [Related]
8. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction.
Steel AW; Postgate AJ; Khorsandi S; Nicholls J; Jiao L; Vlavianos P; Habib N; Westaby D
Gastrointest Endosc; 2011 Jan; 73(1):149-53. PubMed ID: 21184881
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic Therapy in Patients with Advanced Hilar Cholangiocarcinoma: Percutaneous Cholangioscopic Versus Peroral Transpapillary Approach.
Lee TY; Cheon YK; Shim CS
Photomed Laser Surg; 2016 Apr; 34(4):150-6. PubMed ID: 26982507
[TBL] [Abstract][Full Text] [Related]
10. Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction.
Tal AO; Vermehren J; Friedrich-Rust M; Bojunga J; Sarrazin C; Zeuzem S; Trojan J; Albert JG
World J Gastrointest Endosc; 2014 Jan; 6(1):13-9. PubMed ID: 24527176
[TBL] [Abstract][Full Text] [Related]
11. Role of Intraductal RFA: A Novel Tool in the Palliative Care of Perihilar Cholangiocarcinoma.
Weismüller TJ
Visc Med; 2021 Feb; 37(1):39-47. PubMed ID: 33718482
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation for management of malignant biliary obstruction: a single-center experience and review of the literature.
Dutta AK; Basavaraju U; Sales L; Leeds JS
Expert Rev Gastroenterol Hepatol; 2017 Aug; 11(8):779-784. PubMed ID: 28362129
[TBL] [Abstract][Full Text] [Related]
13. Impact of temperature-controlled endobiliary radiofrequency ablation for inoperable hilar cholangiocarcinoma: A propensity score-matched analysis.
Shin IS; Moon JH; Lee YN; Myeong JH; Lee TH; Yang JK; Cho YD; Park SH
Endosc Int Open; 2024 Apr; 12(4):E535-E544. PubMed ID: 38720905
[No Abstract] [Full Text] [Related]
14. Role of radiofrequency ablation in advanced malignant hilar biliary obstruction.
Takenaka M; Lee TH
Clin Endosc; 2023 Mar; 56(2):155-163. PubMed ID: 36646424
[TBL] [Abstract][Full Text] [Related]
15. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.
Witzigmann H; Berr F; Ringel U; Caca K; Uhlmann D; Schoppmeyer K; Tannapfel A; Wittekind C; Mossner J; Hauss J; Wiedmann M
Ann Surg; 2006 Aug; 244(2):230-9. PubMed ID: 16858185
[TBL] [Abstract][Full Text] [Related]
16. Benefits and safety of photodynamic therapy in patients with hilar cholangiocarcinoma: A meta-analysis.
Chen P; Yang T; Shi P; Shen J; Feng Q; Su J
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102712. PubMed ID: 34995788
[TBL] [Abstract][Full Text] [Related]
17. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
[TBL] [Abstract][Full Text] [Related]
18. Surgical procedure and prognosis of hilar cholangiocarcinoma.
Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Chen QB; Wu MC
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):453-7. PubMed ID: 15313688
[TBL] [Abstract][Full Text] [Related]
19. EUS-guided biliary drainage by using a standardized approach for malignant biliary obstruction: rendezvous versus direct transluminal techniques (with videos).
Khashab MA; Valeshabad AK; Modayil R; Widmer J; Saxena P; Idrees M; Iqbal S; Kalloo AN; Stavropoulos SN
Gastrointest Endosc; 2013 Nov; 78(5):734-41. PubMed ID: 23886353
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Endobiliary Radiofrequency Ablation in Preserving Survival, Performance Status and Chemotherapy Eligibility of Patients with Unresectable Distal Cholangiocarcinoma: A Case-Control Study.
Sandru V; Ungureanu BS; Stan-Ilie M; Oprita R; Balan GG; Plotogea OM; Rinja E; Butuc A; Panaitescu A; Constantinescu A; Gheonea DI; Constantinescu G
Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 35892515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
